Alkem Laboratories Ltd. (ALKEM) - Financials, balance sheet (quarterly)

5,126.5 INR

106

2.11%

Last update May 13, 3:29 PM IST

Main market

Day range

5,126.5

5,025

5,145

Previous close

5,020.5

Open

5,028.5

Access this stock data via API

Alkem Laboratories Ltd.

5,126.50

106

2.11%

Financials

Balance sheet

Fiscal date	Sep 2024	Mar 2024	Sep 2023	Mar 2023
Total assets	171.2B	155.7B	149.3B	137.6B
Current assets	111.1B	104.1B	96.6B	87.3B
Cash	—	4.6B	—	2.0B
Cash equivalents	—	0	—	742.1M
Cash and cash equivalents	4.1B	4.6B	3.2B	2.7B
Other short term investments	43.3B	38.1B	35.1B	8.7B
Accounts receivable	25.0B	22.5B	24.5B	21.3B
Other receivables	146.9M	2.1B	102.9M	2.0B
Inventory	29.1B	26.6B	25.4B	26.1B
Prepaid assets	—	7.8B	—	7.1B
Restricted cash	—	2.2B	—	17.9B
Assets held for sale	1.3B	0	664.4M	1.2B
Hedging assets	—	—	—	—
Other current assets	8.1B	214.2M	7.6B	221.1M
Non current assets	60.1B	51.6B	52.6B	50.3B
Properties	22.7B	2.5B	24.0B	1.4B
Land and improvements	—	1.5B	—	1.4B
Machinery furniture equipment	—	23.7B	—	21.7B
Construction in progress	2.9B	1.5B	1.8B	3.1B
Leases	—	—	—	—
Accumulated depreciation	—	-13.8B	—	-11.2B
Goodwill	9.6B	8.9B	9.2B	9.1B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	1.2B	575.8M	858.5M	793.8M
Investments and advances	—	—	—	—
Other non current assets	993.6M	839.5M	699.2M	-100K
Total liabilities	52.1B	48.6B	47.0B	43.2B
Current liabilities	41.8B	39.9B	39.1B	37.1B
Accounts payable	18.9B	17.5B	11.7B	11.7B
Accrued expenses	—	—	—	—
Short term debt	11.4B	11.9B	12.6B	13.3B
Deferred revenue	—	—	—	—
Tax payable	862.7M	549.9M	605.9M	234.4M
Pensions	—	—	—	—
Other current liabilities	2.3B	2.3B	2.0B	100K
Non current liabilities	10.3B	8.7B	7.9B	6.1B
Long term provisions	3.2B	3.0B	4.0B	3.7B
Long term debt	3.4B	2.3B	1.8B	703.3M
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	238.9M	258.4M	278.4M	-200K
Shareholders equity
Common stock	239.1M	239.1M	239.1M	239.1M
Retained earnings	—	83.1B	—	70.5B
Other shareholders equity	—	—	—	—
Total shareholders equity	119.1B	107.1B	102.2B	94.4B
Additional paid in capital	—	—	—	—
Treasury stock	—	—	—	—
Minority interest	4.2B	4.0B	3.8B	3.9B